Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
<h4>Background</h4>We have previously identified genome-wide DNA methylation changes in a cell line model of breast cancer metastasis. These complex epigenetic changes that we observed, along with concurrent karyotype analyses, have led us to hypothesize that complex genomic alterations...
Main Authors: | Joseph Andrews, Wendy Kennette, Jenna Pilon, Alexandra Hodgson, Alan B Tuck, Ann F Chambers, David I Rodenhiser |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20084286/?tool=EBI |
Similar Items
-
Platform comparison of detecting copy number variants with microarrays and whole-exome sequencing
by: Joep de Ligt, et al.
Published: (2014-12-01) -
Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
by: Erica Soster, et al.
Published: (2023-06-01) -
An epigenetic signature of advanced colorectal cancer metastasis
by: Euan J. Rodger, et al.
Published: (2023-06-01) -
P149: Exome sequencing vs chromosomal microarray for copy number variant detection*
by: Kirsty McWalter, et al.
Published: (2024-01-01) -
CNstream: A method for the identification and genotyping of copy number polymorphisms using Illumina microarrays
by: Balsa Alejandro, et al.
Published: (2010-05-01)